Integrated BioPharma receives 3-month extension of PNC line of credit to July 14, 2026

INTEGRATED BIOPHARMA INC

PNC Bank notified Integrated BioPharma and subsidiary Manhattan Drug on April 14, 2026.
Line of credit expiration extended from April 15, 2026 to July 14, 2026.
Extension subject to PNC's sole discretion to designate a later date via written notice.
No changes to other terms of the promissory note dated April 15, 2025 were disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.